首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >Molecular Characterization of Carbapenem-Nonsusceptible Enterobacterial Isolates Collected during a Prospective Interregional Survey in France and Susceptibility to the Novel Ceftazidime-Avibactam and Aztreonam-Avibactam Combinations
【2h】

Molecular Characterization of Carbapenem-Nonsusceptible Enterobacterial Isolates Collected during a Prospective Interregional Survey in France and Susceptibility to the Novel Ceftazidime-Avibactam and Aztreonam-Avibactam Combinations

机译:在法国的前瞻性区域间调查中收集到的碳青霉烯类不敏感肠杆菌分离物的分子特征以及对新型头孢他啶-阿维巴坦和阿兹曲南-阿维巴坦组合的敏感性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

An interregional surveillance program was conducted in the northwestern part of France to determine the prevalence of carbapenem-nonsusceptible Enterobacteriaceae (CNSE) isolates and their susceptibility to ceftazidime-avibactam and aztreonam-avibactam combinations. Nonduplicate CNSE clinical isolates were prospectively collected from six hospitals between June 2012 and November 2013. MICs of ceftazidime and aztreonam, alone or combined with a fixed concentration of avibactam (4 μg/ml), and those of carbapenems (comparator agents) were determined. MICs of ertapenem in combination with phenylalanine arginine-naphthylamide dihydrochloride (PAβN) were also determined to assess active efflux. Genes encoding carbapenemases, plasmid-mediated AmpC enzymes, extended-spectrum β-lactamases (ESBLs), and major outer membrane proteins (OMPs) were amplified and sequenced. OMPs were also extracted for SDS-PAGE analysis. Among the 139 CNSE isolates, mainly Enterobacter spp. and Klebsiella pneumoniae, 123 (88.4%) were ertapenem nonsusceptible, 12 (8.6%) exhibited reduced susceptibility to all carbapenems, and 4 Proteeae isolates (2.9%) were resistant to imipenem. Carbapenemase production was detected in only two isolates (producing OXA-48 and IMI-3). In contrast, OMP deficiency, in association with AmpCs and/or ESBLs (mainly CTX-M-9, SHV-12, and CTX-M-15), was largely identified among CNSE isolates. The ceftazidime-avibactam and aztreonam-avibactam combinations exhibited potent activity against CNSE isolates (MIC50/MIC90, 1/1 μg/ml and 0.5/0.5 μg/ml, respectively) compared to that of ceftazidime and aztreonam alone (MIC50/MIC90, 512/512 μg/ml and 128/512 μg/ml, respectively). This study reveals the in vitro activity of ceftazidime-avibactam and aztreonam-avibactam combinations against a large collection of porin-deficient enterobacterial isolates that are representative of the CNSE recovered in the northern part of France.
机译:在法国西北部进行了区域间监视计划,以确定碳青霉烯非敏感性肠杆菌科(CNSE)分离株的流行情况及其对头孢他啶-阿维巴坦和氨曲南-阿维巴坦组合的敏感性。在2012年6月至2013年11月之间,前瞻性地从六家医院收集了非重复的CNSE临床分离株。确定了头孢他啶和氨曲南的MIC,单独或与固定浓度的阿维巴坦(4μg/ ml)以及碳青霉烯(比较药)的MICs。还确定了厄他培南与苯丙氨酸精氨酸-萘酰胺二盐酸盐(PAβN)结合的MIC,以评估主动外排。扩增并测序了编码碳青霉烯酶,质粒介导的AmpC酶,广谱β-内酰胺酶(ESBLs)和主要外膜蛋白(OMPs)的基因。还提取了OMP用于SDS-PAGE分析。在139种CNSE分离株中,主要是肠杆菌属。肺炎克雷伯菌和肺炎克雷伯菌分别为123例(88.4%)对厄他培南不敏感,12例(8.6%)对所有碳青霉烯类药物的敏感性降低,并且4个Proteeae分离株(2.9%)对亚胺培南有抗药性。仅在两个分离物中检测到碳青霉烯酶的产生(产生OXA-48和IMI-3)。相比之下,在CNSE分离物中主要发现OMP缺乏症与AmpC和/或ESBL(主要是CTX-M-9,SHV-12和CTX-M-15)有关。与单独使用头孢他啶和氨曲南(MIC50 / MIC90,512)相比,头孢他啶-avibactam和氨曲南-avibactam组合表现出对CNSE分离物的有效活性(分别为MIC50 / MIC90、1 / 1μg/ ml和0.5 / 0.5μg/ ml)。 / 512μg/ ml和128/512μg/ ml)。这项研究揭示了头孢他啶-avibactam和aztreonam-avibactam组合对法国北部回收的CNSE代表的大量缺乏孔蛋白的肠杆菌的体外活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号